JD Health lifts operating profit 40.30 percent: what it means for JD Health stock

Published on 10/07/2026 at 05:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached CNY 40.90 billion in the first half of 2026, up 15.90 percent. Analysts set a CNY 61.76 target for JD Health stock.

JD Health, KYG5074A1004, Illustration mit AI erstellt.

JD Health International (ISIN KYG5074A1004) lifted first-half 2026 non-IFRS operating profit 40.30 percent to CNY 3.50 billion, according to GMT Eight on August 13, 2026. The result puts operating efficiency at the center of the JD Health stock story, with the operating margin rising from 7.00 percent to 8.50 percent during the first half of 2026.

Revenue keeps its double-digit pace

GMT Eight reported first-half 2026 revenue of CNY 40.90 billion, an increase of 15.90 percent from the comparable period. That combination of revenue growth and faster operating-profit growth points to improving conversion from sales into earnings.

The same report said online medical-insurance payment services covered 40 cities and that JD Health had established more than 450 pharmacies across 10 cities during the reporting period. Those operating figures show the company is extending beyond online drug purchases into a broader store and home healthcare network.

Analyst expectations remain elevated

Eulerpool reported a 12-month consensus target of CNY 61.76 based on 24 analyst ratings, including 21 Buy and three Hold ratings, in September 2026. The target is a market expectation rather than company guidance, so the key test is whether margin expansion continues as JD Health invests in offline services and artificial intelligence.

Simply Wall St said on October 5, 2026, that its fair value estimate moved from HKD 91.27 to HKD 90.40. The update also reduced its revenue-growth assumption from 21.10 percent to 18.58 percent, highlighting the tension between higher-margin services and slower expected top-line expansion.

Market value and trading context

iPulse AI listed JD Health's market capitalization at HKD 111.0 billion as of September 9, 2026, with the company listed in Hong Kong under ticker 6618.HK. The platform describes JD Health as a digital healthcare business spanning online pharmacy, telemedicine and health management.

On September 18, 2026, JD Health International closed at CNY 31.06 on HKEX, according to Eulerpool. The further course of trading is shown by the continuously updated real-time quote of JD Health stock.